nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—Myocardial ischaemia—Galantamine—Alzheimer's disease	0.0334	0.046	CcSEcCtD
Levosimendan—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.0268	0.037	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.023	0.0317	CcSEcCtD
Levosimendan—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.023	0.0317	CcSEcCtD
Levosimendan—Extrasystoles—Memantine—Alzheimer's disease	0.0224	0.0309	CcSEcCtD
Levosimendan—Extrasystoles—Rivastigmine—Alzheimer's disease	0.0219	0.0303	CcSEcCtD
Levosimendan—Atrial fibrillation—Galantamine—Alzheimer's disease	0.0205	0.0283	CcSEcCtD
Levosimendan—Cardiac failure—Galantamine—Alzheimer's disease	0.0199	0.0275	CcSEcCtD
Levosimendan—Hypokalaemia—Galantamine—Alzheimer's disease	0.0177	0.0244	CcSEcCtD
Levosimendan—Atrial fibrillation—Donepezil—Alzheimer's disease	0.0159	0.022	CcSEcCtD
Levosimendan—Cardiac failure—Donepezil—Alzheimer's disease	0.0155	0.0213	CcSEcCtD
Levosimendan—Atrial fibrillation—Memantine—Alzheimer's disease	0.0145	0.0199	CcSEcCtD
Levosimendan—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.0141	0.0195	CcSEcCtD
Levosimendan—Cardiac failure—Memantine—Alzheimer's disease	0.014	0.0194	CcSEcCtD
Levosimendan—Cardiac failure—Rivastigmine—Alzheimer's disease	0.0137	0.0189	CcSEcCtD
Levosimendan—Hypokalaemia—Donepezil—Alzheimer's disease	0.0137	0.0189	CcSEcCtD
Levosimendan—Cardiac disorder—Galantamine—Alzheimer's disease	0.0125	0.0172	CcSEcCtD
Levosimendan—Hypokalaemia—Memantine—Alzheimer's disease	0.0125	0.0172	CcSEcCtD
Levosimendan—Angiopathy—Galantamine—Alzheimer's disease	0.0122	0.0169	CcSEcCtD
Levosimendan—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.0122	0.0168	CcSEcCtD
Levosimendan—Mental disorder—Galantamine—Alzheimer's disease	0.0118	0.0163	CcSEcCtD
Levosimendan—Malnutrition—Galantamine—Alzheimer's disease	0.0117	0.0162	CcSEcCtD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.0117	0.0426	CbGpPWpGaD
Levosimendan—Nervous system disorder—Galantamine—Alzheimer's disease	0.00938	0.0129	CcSEcCtD
Levosimendan—Tachycardia—Galantamine—Alzheimer's disease	0.00934	0.0129	CcSEcCtD
Levosimendan—Mental disorder—Donepezil—Alzheimer's disease	0.00914	0.0126	CcSEcCtD
Levosimendan—Malnutrition—Donepezil—Alzheimer's disease	0.00909	0.0125	CcSEcCtD
Levosimendan—Hypotension—Galantamine—Alzheimer's disease	0.00894	0.0123	CcSEcCtD
Levosimendan—Cardiac disorder—Memantine—Alzheimer's disease	0.0088	0.0121	CcSEcCtD
Levosimendan—Insomnia—Galantamine—Alzheimer's disease	0.00865	0.0119	CcSEcCtD
Levosimendan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.0086	0.0119	CcSEcCtD
Levosimendan—Angiopathy—Memantine—Alzheimer's disease	0.0086	0.0119	CcSEcCtD
Levosimendan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00841	0.0116	CcSEcCtD
Levosimendan—Mental disorder—Memantine—Alzheimer's disease	0.0083	0.0115	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00826	0.0114	CcSEcCtD
Levosimendan—Malnutrition—Memantine—Alzheimer's disease	0.00825	0.0114	CcSEcCtD
Levosimendan—Constipation—Galantamine—Alzheimer's disease	0.00818	0.0113	CcSEcCtD
Levosimendan—Mental disorder—Rivastigmine—Alzheimer's disease	0.00812	0.0112	CcSEcCtD
Levosimendan—Malnutrition—Rivastigmine—Alzheimer's disease	0.00807	0.0111	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00744	0.0271	CbGpPWpGaD
Levosimendan—Nervous system disorder—Donepezil—Alzheimer's disease	0.00727	0.01	CcSEcCtD
Levosimendan—Hypotension—Donepezil—Alzheimer's disease	0.00693	0.00956	CcSEcCtD
Levosimendan—Insomnia—Donepezil—Alzheimer's disease	0.00671	0.00925	CcSEcCtD
Levosimendan—Nervous system disorder—Memantine—Alzheimer's disease	0.0066	0.00911	CcSEcCtD
Levosimendan—Tachycardia—Memantine—Alzheimer's disease	0.00657	0.00906	CcSEcCtD
Levosimendan—Diarrhoea—Galantamine—Alzheimer's disease	0.00655	0.00903	CcSEcCtD
Levosimendan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00646	0.00891	CcSEcCtD
Levosimendan—Tachycardia—Rivastigmine—Alzheimer's disease	0.00643	0.00887	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0064	0.00883	CcSEcCtD
Levosimendan—Constipation—Donepezil—Alzheimer's disease	0.00634	0.00875	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00633	0.023	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00633	0.023	CbGpPWpGaD
Levosimendan—Dizziness—Galantamine—Alzheimer's disease	0.00633	0.00873	CcSEcCtD
Levosimendan—Hypotension—Memantine—Alzheimer's disease	0.00629	0.00868	CcSEcCtD
Levosimendan—Hypotension—Rivastigmine—Alzheimer's disease	0.00616	0.00849	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00613	0.0223	CbGpPWpGaD
Levosimendan—Insomnia—Memantine—Alzheimer's disease	0.00609	0.0084	CcSEcCtD
Levosimendan—Vomiting—Galantamine—Alzheimer's disease	0.00608	0.00839	CcSEcCtD
Levosimendan—Headache—Galantamine—Alzheimer's disease	0.00599	0.00827	CcSEcCtD
Levosimendan—Insomnia—Rivastigmine—Alzheimer's disease	0.00596	0.00822	CcSEcCtD
Levosimendan—TNNC1—Muscle contraction—CALM1—Alzheimer's disease	0.00587	0.0213	CbGpPWpGaD
Levosimendan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00581	0.00802	CcSEcCtD
Levosimendan—Constipation—Memantine—Alzheimer's disease	0.00576	0.00794	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00569	0.00784	CcSEcCtD
Levosimendan—Nausea—Galantamine—Alzheimer's disease	0.00568	0.00784	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—SLC18A3—Alzheimer's disease	0.00564	0.0205	CbGpPWpGaD
Levosimendan—Constipation—Rivastigmine—Alzheimer's disease	0.00563	0.00777	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00538	0.0196	CbGpPWpGaD
Levosimendan—Diarrhoea—Donepezil—Alzheimer's disease	0.00507	0.007	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00506	0.0184	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00497	0.0181	CbGpPWpGaD
Levosimendan—Dizziness—Donepezil—Alzheimer's disease	0.0049	0.00676	CcSEcCtD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—Alzheimer's disease	0.00486	0.0177	CbGpPWpGaD
Levosimendan—Vomiting—Donepezil—Alzheimer's disease	0.00472	0.0065	CcSEcCtD
Levosimendan—Headache—Donepezil—Alzheimer's disease	0.00465	0.00641	CcSEcCtD
Levosimendan—Diarrhoea—Memantine—Alzheimer's disease	0.00461	0.00635	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00454	0.0165	CbGpPWpGaD
Levosimendan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00451	0.00622	CcSEcCtD
Levosimendan—Dizziness—Memantine—Alzheimer's disease	0.00445	0.00614	CcSEcCtD
Levosimendan—Nausea—Donepezil—Alzheimer's disease	0.0044	0.00607	CcSEcCtD
Levosimendan—Dizziness—Rivastigmine—Alzheimer's disease	0.00436	0.00601	CcSEcCtD
Levosimendan—Vomiting—Memantine—Alzheimer's disease	0.00428	0.0059	CcSEcCtD
Levosimendan—Headache—Memantine—Alzheimer's disease	0.00422	0.00582	CcSEcCtD
Levosimendan—PDE3A—G alpha (s) signalling events—HTR6—Alzheimer's disease	0.0042	0.0153	CbGpPWpGaD
Levosimendan—Vomiting—Rivastigmine—Alzheimer's disease	0.00419	0.00578	CcSEcCtD
Levosimendan—Headache—Rivastigmine—Alzheimer's disease	0.00413	0.00569	CcSEcCtD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00412	0.015	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00408	0.0148	CbGpPWpGaD
Levosimendan—Nausea—Memantine—Alzheimer's disease	0.004	0.00552	CcSEcCtD
Levosimendan—KCNJ8—Neuronal System—GRIK1—Alzheimer's disease	0.00397	0.0145	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CHRNA7—Alzheimer's disease	0.00397	0.0145	CbGpPWpGaD
Levosimendan—Nausea—Rivastigmine—Alzheimer's disease	0.00391	0.0054	CcSEcCtD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—Alzheimer's disease	0.00391	0.0142	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00383	0.0139	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00373	0.0136	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00373	0.0136	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CHAT—Alzheimer's disease	0.00338	0.0123	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GRIK2—Alzheimer's disease	0.00338	0.0123	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GRIA1—Alzheimer's disease	0.00301	0.011	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—MAPK8—Alzheimer's disease	0.0029	0.0106	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00287	0.0104	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—PLCB1—Alzheimer's disease	0.00286	0.0104	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CHRNB2—Alzheimer's disease	0.00285	0.0104	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00278	0.0101	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—IAPP—Alzheimer's disease	0.00273	0.00992	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.00269	0.00978	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00267	0.00972	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—SLC18A3—Alzheimer's disease	0.00267	0.00972	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—CRH—Alzheimer's disease	0.00265	0.00963	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—ACHE—Alzheimer's disease	0.00262	0.00953	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CHRNA4—Alzheimer's disease	0.00259	0.00942	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00259	0.0094	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—NPS—Alzheimer's disease	0.00251	0.00913	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00247	0.00899	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.00245	0.00891	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.00243	0.00886	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00235	0.00856	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—Alzheimer's disease	0.0023	0.00835	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—DOCK3—Alzheimer's disease	0.00229	0.00835	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—BCHE—Alzheimer's disease	0.00228	0.0083	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—PLCB1—Alzheimer's disease	0.00225	0.00817	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—DLG4—Alzheimer's disease	0.00223	0.00811	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GRIN2B—Alzheimer's disease	0.00218	0.00792	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—PLCB1—Alzheimer's disease	0.00215	0.00784	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS2—Alzheimer's disease	0.00189	0.00689	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNA7—Alzheimer's disease	0.00188	0.00685	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIK1—Alzheimer's disease	0.00188	0.00685	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00188	0.00683	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHAT—Alzheimer's disease	0.0016	0.00582	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIK2—Alzheimer's disease	0.0016	0.00582	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—PRKCG—Alzheimer's disease	0.00159	0.0058	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—INS—Alzheimer's disease	0.00156	0.00566	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS3—Alzheimer's disease	0.00152	0.00554	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIA1—Alzheimer's disease	0.00143	0.00519	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CDK5—Alzheimer's disease	0.00142	0.00516	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.00139	0.00507	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00139	0.00506	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CALM1—Alzheimer's disease	0.00138	0.00501	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNB2—Alzheimer's disease	0.00135	0.00491	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—ACHE—Alzheimer's disease	0.00124	0.00451	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CHRNA4—Alzheimer's disease	0.00123	0.00446	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—INS—Alzheimer's disease	0.00122	0.00445	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00118	0.00429	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—CREB1—Alzheimer's disease	0.00118	0.00429	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CLU—Alzheimer's disease	0.00112	0.00408	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—BCHE—Alzheimer's disease	0.00108	0.00393	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—DLG4—Alzheimer's disease	0.00106	0.00384	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PYY—Alzheimer's disease	0.00103	0.00376	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GRIN2B—Alzheimer's disease	0.00103	0.00375	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—PLCB1—Alzheimer's disease	0.00102	0.00371	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.00101	0.00368	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—A2M—Alzheimer's disease	0.000999	0.00363	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000981	0.00357	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—DHCR24—Alzheimer's disease	0.000971	0.00353	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PYY—Alzheimer's disease	0.000938	0.00341	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000863	0.00314	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—INPP5D—Alzheimer's disease	0.000859	0.00313	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TF—Alzheimer's disease	0.000849	0.00309	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA4—Alzheimer's disease	0.000825	0.003	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000816	0.00297	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CDK5—Alzheimer's disease	0.000814	0.00296	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR6—Alzheimer's disease	0.000783	0.00285	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GAB2—Alzheimer's disease	0.000777	0.00283	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GAPDHS—Alzheimer's disease	0.000776	0.00282	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APP—Alzheimer's disease	0.000757	0.00275	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—PRKCG—Alzheimer's disease	0.000754	0.00274	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ATP5A1—Alzheimer's disease	0.000736	0.00268	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GAL—Alzheimer's disease	0.000716	0.00261	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLD3—Alzheimer's disease	0.000702	0.00255	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD17B10—Alzheimer's disease	0.000673	0.00245	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CALM1—Alzheimer's disease	0.000653	0.00237	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GAL—Alzheimer's disease	0.00065	0.00237	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP46A1—Alzheimer's disease	0.000648	0.00236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TTR—Alzheimer's disease	0.000634	0.00231	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ND1—Alzheimer's disease	0.000625	0.00228	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SOD1—Alzheimer's disease	0.000617	0.00225	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF2—Alzheimer's disease	0.000586	0.00213	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000563	0.00205	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000559	0.00203	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—CREB1—Alzheimer's disease	0.000559	0.00203	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PYY—Alzheimer's disease	0.000554	0.00202	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000543	0.00198	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PRKCG—Alzheimer's disease	0.000528	0.00192	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000515	0.00187	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NPY—Alzheimer's disease	0.000511	0.00186	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000508	0.00185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CRH—Alzheimer's disease	0.000493	0.00179	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000491	0.00179	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SST—Alzheimer's disease	0.000491	0.00179	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDK5—Alzheimer's disease	0.000481	0.00175	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—APP—Alzheimer's disease	0.000478	0.00174	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—NPS—Alzheimer's disease	0.000467	0.0017	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000465	0.00169	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR6—Alzheimer's disease	0.000463	0.00168	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—Alzheimer's disease	0.000462	0.00168	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CALM1—Alzheimer's disease	0.000457	0.00166	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000451	0.00164	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CAV1—Alzheimer's disease	0.000451	0.00164	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000446	0.00162	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SST—Alzheimer's disease	0.000446	0.00162	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—APP—Alzheimer's disease	0.000434	0.00158	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—F2—Alzheimer's disease	0.000429	0.00156	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—Alzheimer's disease	0.000424	0.00154	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSENEN—Alzheimer's disease	0.00042	0.00153	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APH1A—Alzheimer's disease	0.000414	0.00151	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00041	0.00149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000403	0.00147	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CHAT—Alzheimer's disease	0.000403	0.00147	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TPI1—Alzheimer's disease	0.000403	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LRP1—Alzheimer's disease	0.000393	0.00143	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MAOB—Alzheimer's disease	0.000386	0.00141	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GFAP—Alzheimer's disease	0.000384	0.0014	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAL—Alzheimer's disease	0.000384	0.0014	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—Alzheimer's disease	0.000376	0.00137	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GAPDH—Alzheimer's disease	0.000372	0.00135	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—A2M—Alzheimer's disease	0.000359	0.00131	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—Alzheimer's disease	0.000341	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—A2M—Alzheimer's disease	0.000339	0.00123	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000334	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000328	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000316	0.00115	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACHE—Alzheimer's disease	0.000312	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.00031	0.00113	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INPP5D—Alzheimer's disease	0.000309	0.00112	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000303	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NPY—Alzheimer's disease	0.000302	0.0011	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IAPP—Alzheimer's disease	0.0003	0.00109	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO1—Alzheimer's disease	0.000293	0.00107	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS1—Alzheimer's disease	0.000293	0.00107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CRH—Alzheimer's disease	0.000291	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000287	0.00105	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2D6—Alzheimer's disease	0.000287	0.00104	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000281	0.00102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NPS—Alzheimer's disease	0.000276	0.001	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000275	0.000999	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—BCHE—Alzheimer's disease	0.000272	0.00099	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—F2—Alzheimer's disease	0.000271	0.000987	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000271	0.000985	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000263	0.000958	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SST—Alzheimer's disease	0.000263	0.000958	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GAB2—Alzheimer's disease	0.000263	0.000958	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000262	0.000954	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000261	0.00095	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCB1—Alzheimer's disease	0.000257	0.000934	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APP—Alzheimer's disease	0.000257	0.000934	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCA1—Alzheimer's disease	0.000249	0.000906	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—F2—Alzheimer's disease	0.000246	0.000897	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—Alzheimer's disease	0.000246	0.000894	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000242	0.000881	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NGFR—Alzheimer's disease	0.000226	0.000822	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—Alzheimer's disease	0.000226	0.000821	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000225	0.000817	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000221	0.000803	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL2—Alzheimer's disease	0.00022	0.000799	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARGC1A—Alzheimer's disease	0.000215	0.000781	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—Alzheimer's disease	0.000214	0.000777	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—S100B—Alzheimer's disease	0.000209	0.000759	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF2—Alzheimer's disease	0.000199	0.000723	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPL—Alzheimer's disease	0.000195	0.000711	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000192	0.000699	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—Alzheimer's disease	0.000186	0.000676	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPL—Alzheimer's disease	0.000184	0.00067	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000183	0.000664	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000179	0.000652	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—Alzheimer's disease	0.000176	0.00064	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NGF—Alzheimer's disease	0.000174	0.000635	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR5—Alzheimer's disease	0.00017	0.000617	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000166	0.000604	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CALM1—Alzheimer's disease	0.000164	0.000598	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOE—Alzheimer's disease	0.000164	0.000596	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAV1—Alzheimer's disease	0.000162	0.00059	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—Alzheimer's disease	0.000157	0.000571	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALM1—Alzheimer's disease	0.000155	0.000564	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—Alzheimer's disease	0.000154	0.000562	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOE—Alzheimer's disease	0.000154	0.000562	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CAV1—Alzheimer's disease	0.000153	0.000557	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ESR1—Alzheimer's disease	0.000147	0.000536	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2—Alzheimer's disease	0.000146	0.00053	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—Alzheimer's disease	0.000143	0.000519	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000142	0.000518	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INS—Alzheimer's disease	0.00014	0.000509	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GSK3B—Alzheimer's disease	0.000134	0.000486	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREB1—Alzheimer's disease	0.000133	0.000483	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INS—Alzheimer's disease	0.000132	0.00048	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL2—Alzheimer's disease	0.00013	0.000472	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—Alzheimer's disease	0.000128	0.000464	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—Alzheimer's disease	0.000123	0.000446	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—Alzheimer's disease	0.000116	0.000421	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—Alzheimer's disease	0.000112	0.000408	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—Alzheimer's disease	9.91e-05	0.000361	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—Alzheimer's disease	9.82e-05	0.000357	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—Alzheimer's disease	9.76e-05	0.000355	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK8—Alzheimer's disease	9.03e-05	0.000328	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—Alzheimer's disease	9e-05	0.000327	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—Alzheimer's disease	8.33e-05	0.000303	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—Alzheimer's disease	7.65e-05	0.000278	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—Alzheimer's disease	6.3e-05	0.000229	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—Alzheimer's disease	5.76e-05	0.00021	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—Alzheimer's disease	5.64e-05	0.000205	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—Alzheimer's disease	5.32e-05	0.000193	CbGpPWpGaD
